ASSOCIATED BANC-CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ASSOCIATED BANC-CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.10B | Feb 8, 2024 |
| FY2023 | Dec 31, 2022 | $1.24B | Feb 8, 2024 |
| FY2023 | Dec 31, 2021 | $1.06B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $1.28B | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $1.22B | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $1.24B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $1.07B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.06B | Feb 19, 2019 |
| FY2017 | Dec 31, 2015 | $1.01B | Feb 6, 2018 |
| FY2016 | Dec 31, 2014 | $971.83M | Feb 6, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $474.78M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $123.15M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $182.96M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $366.12M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $350.99M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $306.77M | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $326.79M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $333.56M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $229.26M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $200.27M | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $615.69M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $580.25M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $442.74M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $846.57M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $529.55M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $550.02M | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $574.26M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $496.57M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $458.37M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $641.38M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.20B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $43.02B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $41.02B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $39.41B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $35.10B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $33.42B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $32.39B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $33.62B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $30.48B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $29.14B | Feb 6, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.23B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $38.42B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $36.84B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $35.39B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $31.08B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $29.33B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $28.46B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $29.83B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $27.25B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $26.05B | Feb 6, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.98B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.61B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.17B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $4.02B | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $4.02B | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $4.09B | Feb 8, 2024 |
| FY2022 | Dec 31, 2019 | $3.92B | Feb 13, 2023 |
| FY2021 | Dec 31, 2018 | $3.78B | Feb 8, 2022 |
| FY2020 | Dec 31, 2017 | $3.24B | Feb 9, 2021 |
| FY2019 | Dec 31, 2016 | $3.09B | Feb 11, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.10B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.10B | Feb 8, 2024 |
| FY2023 | Dec 31, 2021 | $1.10B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $1.11B | Feb 13, 2023 |
| FY2020 | Dec 31, 2019 | $1.18B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $1.17B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $976.24M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $971.95M | Feb 6, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.23B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.92B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.95B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.90B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $2.67B | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | $2.46B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $2.38B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $2.18B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $1.93B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.70B | Feb 6, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $716.02M | Feb 6, 2018 |
| FY2016 | Dec 31, 2016 | $642.23M | Feb 6, 2017 |
| FY2015 | Dec 31, 2015 | $473.69M | Feb 5, 2016 |
| FY2015 | Dec 31, 2014 | $1.03B | Feb 5, 2016 |
| FY2015 | Dec 31, 2013 | $602.25M | Feb 5, 2016 |
| FY2015 | Dec 31, 2012 | $737.87M | Feb 5, 2016 |
| FY2011 | Dec 31, 2011 | $616.60M | Feb 28, 2012 |
| FY2010 | Dec 31, 2010 | $868.16M | Feb 15, 2011 |
| FY2010 | Dec 31, 2009 | $820.69M | Feb 15, 2011 |
| FY2010 | Dec 31, 2008 | $570.73M | Feb 15, 2011 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 12, 2026 |
| FY2024 | Dec 31, 2024 | $1.44B | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $1.74B | Feb 8, 2024 |
| FY2022 | Dec 31, 2022 | $1.44B | Feb 13, 2023 |
| FY2021 | Dec 31, 2021 | $1.87B | Feb 8, 2022 |
| FY2020 | Dec 31, 2020 | $549.47M | Feb 9, 2021 |
| FY2019 | Dec 31, 2019 | $3.21B | Feb 11, 2020 |
| FY2018 | Dec 31, 2018 | $3.47B | Feb 19, 2019 |
| FY2017 | Dec 31, 2017 | $3.40B | Feb 6, 2018 |
| FY2017 | Dec 31, 2016 | $2.76B | Feb 6, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 19, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 19, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 165.98M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 166.18M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 151.04M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 150.44M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 149.34M | Feb 13, 2023 |
| FY2021 | Dec 31, 2020 | 153.54M | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | 157.17M | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | 164.44M | Feb 11, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.77M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $139.20M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $129.53M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $123.14M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $116.06M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $112.02M | Feb 13, 2023 |
| FY2021 | Dec 31, 2019 | $111.80M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $105.52M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $76.42M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $67.86M | Feb 19, 2019 |